Pulmonx (LUNG) Return on Capital Employed (2020 - 2025)
Pulmonx (LUNG) posted quarterly Return on Capital Employed of 47.7% for Q3 2025, down 934.0% year-over-year from 5.72% in Q3 2024, and down 6.05% quarter-over-quarter from 44.99% in Q2 2025.
Pulmonx (LUNG) Return on Capital Employed (2020 - 2025) Analysis & Trends
Pulmonx (LUNG) has reported Return on Capital Employed for 6 consecutive years, with 47.7% the latest figure, recorded in Q3 2025.
- In Q3 2025, Return on Capital Employed fell 934.0% year-over-year to 47.7%; the TTM figure through Sep 2025 stood at 47.7% (down 934.0% YoY), while the FY2024 annual figure was 39.56%, down 146.0% from the prior year.
- Return on Capital Employed declined to 47.7% in Q3 2025 per LUNG's latest filing, from 44.99% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 15.77% in Q1 2021 and bottomed at 47.7% in Q3 2025.
- Historically, Return on Capital Employed has averaged 32.92% across 5 years, with a median of 34.56% in 2023.
- Annual changes were most pronounced in 2021 — Return on Capital Employed decreased 30 bps — and 2022, when it slumped 1151 bps.
- Pulmonx's Return on Capital Employed stood at 21.17% in 2021, then tumbled by 54 bps to 32.68% in 2022, then dropped by 20 bps to 39.14% in 2023, then fell by 5 bps to 41.02% in 2024, then declined by 16 bps to 47.7% in 2025.
- Business Quant data shows LUNG's Return on Capital Employed at 47.7% in Q3 2025, 44.99% in Q2 2025, and 43.79% in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 12.08% |
| 10 | Pulmonx | 94.56 Mn | 24.81 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -47.70% |
| Jun 30, 2025 | -44.99% |
| Mar 31, 2025 | -43.79% |
| Dec 31, 2024 | -41.02% |
| Sep 30, 2024 | -38.37% |
| Jun 30, 2024 | -38.90% |
| Mar 31, 2024 | -40.08% |
| Dec 31, 2023 | -39.14% |
| Sep 30, 2023 | -37.16% |
| Jun 30, 2023 | -34.56% |
| Mar 31, 2023 | -32.91% |
| Dec 31, 2022 | -32.68% |
| Sep 30, 2022 | -30.35% |
| Jun 30, 2022 | -26.45% |
| Mar 31, 2022 | -23.89% |
| Dec 31, 2021 | -21.17% |
| Sep 30, 2021 | -19.63% |
| Jun 30, 2021 | -16.91% |
| Mar 31, 2021 | -15.77% |
| Dec 31, 2020 | -20.87% |